101 related articles for article (PubMed ID: 8888321)
1. Effects of a 2.5-mg silver acetate lozenge on initial and long-term smoking cessation.
Hymowitz N; Eckholdt H
Prev Med; 1996; 25(5):537-46. PubMed ID: 8888321
[TBL] [Abstract][Full Text] [Related]
2. Silver acetate interactions with nicotine and non-nicotine smoke components.
Rose JE; Behm FM; Murugesan T; McClernon FJ
Exp Clin Psychopharmacol; 2010 Dec; 18(6):462-9. PubMed ID: 21186921
[TBL] [Abstract][Full Text] [Related]
3. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
4. Nicotine lozenge efficacy in light smokers.
Shiffman S
Drug Alcohol Depend; 2005 Mar; 77(3):311-4. PubMed ID: 15734231
[TBL] [Abstract][Full Text] [Related]
5. The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day.
Daughton DM; Fortmann SP; Glover ED; Hatsukami DK; Heatley SA; Lichtenstein E; Repsher L; Millatmal T; Killen JD; Nowak RT; Ullrich F; Patil KD; Rennard SI
Prev Med; 1999 Feb; 28(2):113-8. PubMed ID: 10048102
[TBL] [Abstract][Full Text] [Related]
6. Silver acetate for smoking cessation.
Lancaster T; Stead LF
Cochrane Database Syst Rev; 2000; (2):CD000191. PubMed ID: 10796505
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR
Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342
[TBL] [Abstract][Full Text] [Related]
8. Silver acetate for smoking cessation.
Lancaster T; Stead LF
Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD000191. PubMed ID: 22972041
[TBL] [Abstract][Full Text] [Related]
9. Long-term use of nicotine vs placebo gum.
Hughes JR; Gust SW; Keenan R; Fenwick JW; Skoog K; Higgins ST
Arch Intern Med; 1991 Oct; 151(10):1993-8. PubMed ID: 1929687
[TBL] [Abstract][Full Text] [Related]
10. Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers.
Shiffman S; Sweeney CT; Ferguson SG; Sembower MA; Gitchell JG
Clin Ther; 2008 Oct; 30(10):1852-8. PubMed ID: 19014840
[TBL] [Abstract][Full Text] [Related]
11. The English smoking treatment services: one-year outcomes.
Ferguson J; Bauld L; Chesterman J; Judge K
Addiction; 2005 Apr; 100 Suppl 2():59-69. PubMed ID: 15755262
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression.
Cox LS; Patten CA; Niaura RS; Decker PA; Rigotti N; Sachs DP; Buist AS; Hurt RD
J Gen Intern Med; 2004 Aug; 19(8):828-34. PubMed ID: 15242467
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
Prochazka AV; Kick S; Steinbrunn C; Miyoshi T; Fryer GE
Arch Intern Med; 2004 Nov; 164(20):2229-33. PubMed ID: 15534159
[TBL] [Abstract][Full Text] [Related]
14. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
[TBL] [Abstract][Full Text] [Related]
15. Silver acetate mouth spray as an aid in smoking cessation: results of a double-blind trial.
Morrow R; Nepps P; McIntosh M
J Am Board Fam Pract; 1993; 6(4):353-7. PubMed ID: 8352038
[TBL] [Abstract][Full Text] [Related]
16. Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial.
Shiffman S; Ferguson SG; Strahs KR
Am J Prev Med; 2009 Feb; 36(2):96-104.e1. PubMed ID: 19135903
[TBL] [Abstract][Full Text] [Related]
17. Safety profile of a nicotine lozenge compared with that of nicotine gum in adult smokers with underlying medical conditions: a 12-week, randomized, open-label study.
Marsh HS; Dresler CM; Choi JH; Targett DA; Gamble ML; Strahs KR
Clin Ther; 2005 Oct; 27(10):1571-87. PubMed ID: 16330293
[TBL] [Abstract][Full Text] [Related]
18. A comparison of a nicotine sublingual tablet and placebo for smoking cessation.
Glover ED; Glover PN; Franzon M; Sullivan CR; Cerullo CC; Howell RM; Keyes GG; Nilsson F; Hobbs GR
Nicotine Tob Res; 2002 Nov; 4(4):441-50. PubMed ID: 12521403
[TBL] [Abstract][Full Text] [Related]
19. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse.
Covey LS; Glassman AH; Jiang H; Fried J; Masmela J; LoDuca C; Petkova E; Rodriguez K
Addiction; 2007 Aug; 102(8):1292-302. PubMed ID: 17624979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
